CAS: 2088939-99-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LYN-1604 REF: AN-AG01EOPNCAS: 2088939-99-3 | ≥98% | To inquire | Thu 16 May 24 |
 | LYN-1604 REF: TM-T4123CAS: 2088939-99-3 | 98% | 92.00 €~1,068.00 € | Fri 17 May 24 |
 | LYN-1604 REF: 3D-NID93999CAS: 2088939-99-3 | Min. 95% | To inquire | Thu 27 Jun 24 |
Ref: AN-AG01EOPN
| 1mg | 103.00 € | |
| 5mg | 237.00 € | |
| 10mg | 528.00 € | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 16 May 2024
LYN-1604
CAS:2088939-99-3
LYN-1604 is a novel activator of ULK1, inducing cell death involved in ATF3, RAD21, and …
Formula:
C33H43Cl2N3O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
584.62
Ref: TM-T4123
| 25mg | 592.00 € | |
| 50mg | 775.00 € | |
| 100mg | 1,068.00 € | |
| 1ml*10 (DMSO) | 277.00 € |
Estimated delivery in United States, on Friday 17 May 2024
LYN-1604
CAS:2088939-99-3
LYN-1604 is a small-molecule drug that is a potential drug target for cancer therapy. It …
Formula:
C33H45Cl4N3O2
Purity:
Min. 95%
Molecular weight:
657.54 g/mol
Ref: 3D-NID93999
| 1mg | To inquire | |
| 2mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Estimated delivery in United States, on Thursday 27 Jun 2024
